<?xml version='1.0' encoding='utf-8'?>
<document id="25888521"><sentence text="Analysis of drug interactions at the end of life." /><sentence text="As death approaches, patients are at their most frail, but an increasing symptom burden often necessitates an increase in medications, putting them at higher risk for drug-drug interactions" /><sentence text="" /><sentence text="To assess the potential for drug-drug interactions in routine prescribing at the end of life" /><sentence text="" /><sentence text="An Australian retrospective multicentre case-note review of 266 consecutive adult patients who were referred to specialist palliative care, with data available on 166" /><sentence text=" Medications used in the last 2â€…weeks of life were screened for potential interactions using the 'Stockley's Drug Interactions' software" /><sentence text="" /><sentence text="The mean number of medications prescribed was 10" /><sentence text="8, median 9 (IQR 6-14); all patients received at least one medication" /><sentence text=" In this study, 72% of patients were at risk of 1 or more potential drug-drug interaction" /><sentence text=" The mean number of potential interactions was 4" /><sentence text="4, with a median of 2" /><sentence text="5 (IQR 0-7) per patient" /><sentence text=" There were only 4/166 (2" /><sentence text="4%) prescribed medications with an associated clinical record of an adverse drug reaction" /><sentence text="" /><sentence text="Potential drug-drug interactions are common for this group of patients" /><sentence text=" Some interactions may be recognised as an acceptable risk when the prescription is written" /><sentence text=" Further research is necessary to determine the best way to improve recognition of potential drug-drug interactions and the rates of morbidity or accelerated mortality associated with this" /><sentence text=" It is likely that palliative care services will need to implement multiple strategies including greater use of computerised prescribing software, and greater closer liaison with clinical pharmacists" /><sentence text="" /></document>